Medtronic
Trade Medtronic 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MDT
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit.
MDT Key Statistics
Stock Snapshot
The current Medtronic(MDT) stock price is $96.21, with a market capitalization of 123.34B. The stock trades at a price-to-earnings (P/E) ratio of 26.19 and offers a dividend yield of 2.9%.
As of 2026-01-14, Medtronic(MDT) stock has fluctuated between $96.04 and $96.85. The current price stands at $96.21, placing the stock +0.2% above today's low and -0.7% off the high.
The Medtronic(MDT)'s current trading volume is 401.26K, compared to an average daily volume of 6.05M.
In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $79.55.
In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $79.55.
MDT News
If you are wondering whether Medtronic is fairly priced or offering value right now, you are not alone. This article is built to help you answer that question w...
Precision Neuroscience Corporation announced a strategic partnership with Medtronic (MDT) to advance neurosurgery, leveraging Precision’s brain-computer interfa...
Medtronic (MDT) announced U.S. FDA 510(k) clearance of its MiniMed Go app. The MiniMed Go Smart Multiple Daily Injection system seamlessly integrates the InPen...
Analyst ratings
57%
of 30 ratingsMore MDT News
Key Points Vertex and Medtronic could see strong momentum this year, while Pfizer is still facing challenges. Regardless of what happens in 2026, though, Vert...
Bernstein raised the firm’s price target on Medtronic (MDT) to $112 from $111 and keeps an Outperform rating on the shares. After a low point in September 2025,...
In early January 2026, Medtronic reported real-world data in Diabetes Care showing its MiniMed 780G insulin pump helped users reach American Diabetes Associatio...